Investing.com - Biogen (NASDAQ:BIIB) reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $10.26 on revenue of $3.68B. Analysts polled by Investing.com anticipated EPS of $8.03 on revenue of $3.44B.
Biogen shares are down 5% from the beginning of the year and are trading at $280.19 , down-from-52-week-high.They are under-performing the Nasdaq 100 which is up 24.05% from the start of the year.
Biogen follows other major Healthcare sector earnings this month
Biogen's report follows an earnings beat by J&J on Thursday, July 16, 2020, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Novartis ADR had beat expectations on Tuesday with second quarter EPS of $1.36 on revenue of $11.35B, compared to forecast for EPS of $1.34 on revenue of $11.9B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar